Skip to main content
. 2020 Dec 3;10:21149. doi: 10.1038/s41598-020-77875-5

Figure 4.

Figure 4

Receiver operating characteristic curves to assess changes in the standardized uptake value (ΔSUV), metabolic tumor volume (ΔMTV), total lesion glycolysis (ΔTLG), and apparent diffusion coefficient (ΔADC) for distinguishing between responders and non-responders in patients with (ad) human epidermal growth factor receptor-2 (HER2)-negative and (eh) triple-negative breast cancer. AUC area under the curve.